SCHEMBL14168697

SCHEMBL14168697

O=S(=O)(CI)c1ccc(-c2noc(C(F)(F)F)c2-c2ccccc2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 16/20 0.72
ESR1 P03372 1/20 0.61
ESR2 Q92731 1/20 0.61
PTGS1 P23219 6/20 0.48
MT-CO2 P00403 3/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
LMNA P02545 1/20 0.46
CA3 P07451 1/20 0.46
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CHRM1 P11229 1/20 0.46
ADRA2B P18089 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
SLC6A2 P23975 1/20 0.46
PDE4A P27815 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24334940 0.89 PTGS2 (0.77) PTGS2ESR1ESR2PTGS1MT-CO2
SCHEMBL22828114 0.87 PTGS2 (0.70) PTGS2ESR1ESR2PTGS1MT-CO2
SCHEMBL6248342 0.84 PTGS2 (0.77) PTGS2ESR1ESR2PTGS1MT-CO2
SCHEMBL4800056 0.84 PTGS2 (1.00) PTGS2ESR1ESR2PTGS1MT-CO2
SCHEMBL14163959 0.84 PTGS2 (1.00) PTGS2ESR1ESR2PTGS1MT-CO2
SCHEMBL5698365 0.84 PTGS2 (0.77) PTGS2ESR1ESR2PTGS1MT-CO2
SCHEMBL6439781 0.76 ESR1 (1.00) PTGS2ESR1ESR2PTGS1MEN1
SCHEMBL27955684 0.75 ESR1 (0.64) PTGS2ESR1ESR2PTGS1MT-CO2
SCHEMBL4806543 0.75 PTGS2 (0.83) PTGS2ESR1ESR2PTGS1MT-CO2
SCHEMBL22827969 0.73 PTGS2 (1.00) PTGS2ESR1ESR2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080138282-A1 imaging agents for the cyclooxygenase (COX-2) enzyme using positronemission tomograpy (PET); C11 or F18 radioisotopes; inflammatory, cancer, diabetes, neurodegenerative diseases THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2008-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080138282-A1 imaging agents for the cyclooxygenase (COX-2) enzyme using positronemission tomograpy (PET); C11 or F18 radioisotopes; inflammatory, cancer, diabetes, neurodegenerative diseases PTGES2, PTGES, PTGS2 PTGS2 3/4885ESR1 454/4885ESR2 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.